Insider Transactions Reported by 16 Insiders of Immuneering Corp

Symbol
IMRX on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Immuneering Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Cormorant Asset Management, LP 10%+ Owner $8,598,961 01 Apr 2024
Peter Feinberg Director $6,947,380 +$288,747 +4.3% 12 Jan 2026
BENJAMIN J. ZESKIND PRESIDENT AND CEO, Director, 10%+ Owner $4,651,279 +$50,144 +1.1% 01 Jul 2025
Brett Matthew Hall Chief Scientific Officer $1,720,586 +$45,118 +2.7% 15 Jan 2026
Scott Barrett Chief Medical Officer $1,452,765 15 Feb 2023
Biren Amin Cfo, Treasurer $934,423 12 May 2022
Thomas J. Schall Director $193,659 +$124,066 +178% 27 Jun 2025
Mallory Morales Chief Accounting Officer $175,935 +$1,917 +1.1% 01 Oct 2025
Leah R. Neufeld Chief People Officer $107,853 +$16,009 +17% 13 Jan 2026
Michael D. Bookman Chief Legal Officer, Secretary $33,261 +$6,966 +26% 01 Oct 2025
Harold Eugene Brakewood Chief Business Officer $14,665 +$4,804 +49% 20 Jun 2025
DIANA HAUSMAN Director $7,975 02 Jul 2025
LAURIE KEATING Director 01 Jan 2026
ANN E. BERMAN Director 13 Jun 2025
CARPENTER ROBERT J Director 13 Jun 2025
Igor Matushansky Chief Medical Officer 21 Mar 2025

Recent Insider Transactions by Companies or Individuals for Immuneering Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.